123 related articles for article (PubMed ID: 2421645)
21. Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients.
Atzpodien J; Morawek L; Fluck M; Reitz M
Cancer Chemother Pharmacol; 2009 Oct; 64(5):901-5. PubMed ID: 19229537
[TBL] [Abstract][Full Text] [Related]
22. [Intralesional therapy of melanoma metastases with recombinant interferon-beta].
Fierlbeck G; d'Hoedt B; Stroebel W; Stutte H; Bogenschütz O; Rassner G
Hautarzt; 1992 Jan; 43(1):16-21. PubMed ID: 1612904
[TBL] [Abstract][Full Text] [Related]
23. [New combination chemotherapy for malignant melanoma--PAV(peplomycin, ACNU, VCR) therapy].
Ikeda S; Tajima K; Miyasato H; Terakado T; Suzuki T; Miura T
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2198-204. PubMed ID: 6194756
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian Cooperative Oncology Group.
Daponte A; Ascierto PA; Gravina A; Melucci MT; Palmieri G; Comella P; Cellerino R; DeLena M; Marini G; Comella G;
Cancer; 2000 Dec; 89(12):2630-6. PubMed ID: 11135225
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of neoadjuvant biochemotherapy for stage III melanoma.
Gibbs P; Anderson C; Pearlman N; LaClaire S; Becker M; Gatlin K; O'Driscoll M; Stephens J; Gonzalez R
Cancer; 2002 Jan; 94(2):470-6. PubMed ID: 11900232
[TBL] [Abstract][Full Text] [Related]
26. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
[TBL] [Abstract][Full Text] [Related]
27. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
[TBL] [Abstract][Full Text] [Related]
28. Randomized phase 2/3 trial of CpG oligodeoxynucleotide PF-3512676 alone or with dacarbazine for patients with unresectable stage III and IV melanoma.
Weber JS; Zarour H; Redman B; Trefzer U; O'Day S; van den Eertwegh AJ; Marshall E; Wagner S
Cancer; 2009 Sep; 115(17):3944-54. PubMed ID: 19536884
[TBL] [Abstract][Full Text] [Related]
29. Clinical relevance of ICAM-1 expression in primary lesions and serum of patients with malignant melanoma.
Kageshita T; Yoshii A; Kimura T; Kuriya N; Ono T; Tsujisaki M; Imai K; Ferrone S
Cancer Res; 1993 Oct; 53(20):4927-32. PubMed ID: 8104688
[TBL] [Abstract][Full Text] [Related]
30. Results of two sequential phase II studies of interleukin-2 (IL2) in metastatic renal cell carcinoma and melanoma: high-dose continuous intravenous IL2 infusion and subcutaneous IL2 administration in combination with alpha interferon.
Hidalgo OF; Aramendía JM; Alonso G; Foncillas JG; Brugarolas A
Rev Med Univ Navarra; 1996; 40(3):6-12. PubMed ID: 9499820
[TBL] [Abstract][Full Text] [Related]
31. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
Garbe C
Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of malignant melanoma: recent advances and perspectives].
Saida T
Gan To Kagaku Ryoho; 1997 Jan; 24(1):10-5. PubMed ID: 9020939
[TBL] [Abstract][Full Text] [Related]
34. [Systemic therapy of metastatic malignant melanoma].
Stahel RA; Martz G
Schweiz Rundsch Med Prax; 1988 Apr; 77(17):459-62. PubMed ID: 3259710
[No Abstract] [Full Text] [Related]
35. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
36. Randomized trial of recombinant alpha 2b-interferon with or without indomethacin in patients with metastatic malignant melanoma.
Miller RL; Steis RG; Clark JW; Smith JW; Crum E; McKnight JE; Hawkins MJ; Jones MJ; Longo DL; Urba WJ
Cancer Res; 1989 Apr; 49(7):1871-6. PubMed ID: 2647294
[TBL] [Abstract][Full Text] [Related]
37. [Alpha 2 -interferon therapy in metastasizing malignant melanoma].
Landthaler M; Geyer C; Papendick U; Braun-Falco O
Dtsch Med Wochenschr; 1987 Jun; 112(23):919-21. PubMed ID: 3582200
[TBL] [Abstract][Full Text] [Related]
38. [Clinical trials of human fibroblast interferon (Hu IFN-beta) in the treatment of malignant tumors of the skin].
Ishihara K
Nihon Gan Chiryo Gakkai Shi; 1983 Feb; 18(1):41-53. PubMed ID: 6345697
[No Abstract] [Full Text] [Related]
39. [Recombinant leukocyte A interferon in metastasized malignant melanoma].
Elsässer-Beile U; Schöpf E; Neumann HA; Drews H; Hundhammer K; Balda BR
Dtsch Med Wochenschr; 1987 Mar; 112(10):373-7. PubMed ID: 3816582
[TBL] [Abstract][Full Text] [Related]
40. [The prevention of skin melanoma metastases to the regional lymph nodes].
Korovin SI; Tolstopiatov BA
Vrach Delo; 1990 Apr; (4):80-1. PubMed ID: 2275181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]